Characterisation of Symptom and Polysomnographic Profiles Associated with Cardiovascular Risk in a Sleep Clinic Population with Obstructive Sleep Apnoea
DOI: https://doi.org/10.2147/nss.s453259
2024-05-06
Nature and Science of Sleep
Abstract:Emily Kemp, 1 Kate Sutherland, 1– 3 Yu Sun Bin, 2, 3 Andrew SL Chan, 1– 3 Hasthi Dissanayake, 2, 3 Brendon J Yee, 2– 5 Kristina Kairaitis, 2, 3, 6, 7 John Robert Wheatley, 2, 3, 6, 7 Philip de Chazal, 2, 8 Amanda J Piper, 2, 4 Peter A Cistulli 1– 3 On behalf of the Sydney Sleep Biobank Investigators 1 Department of Respiratory Medicine, Royal North Shore Hospital, St Leonards, NSW, Australia; 2 Charles Perkins Centre, University of Sydney, Camperdown, NSW, Australia; 3 Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia; 4 Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; 5 Centre for Integrated Research and Understanding of Sleep (CIRUS), Woolcock Institute of Medical Research, Glebe, NSW, Australia; 6 Ludwig Engel Centre for Respiratory Research, Westmead Institute for Medical Research, Westmead, NSW, Australia; 7 Department of Respiratory and Sleep Medicine, Westmead Hospital, Westmead, NSW, Australia; 8 School of Biomedical Engineering, The University of Sydney, Darlington, NSW, Australia Correspondence: Peter A Cistulli, Department of Respiratory and Sleep Medicine, Level 8A, Royal North Shore Hospital, St Leonards, NSW, 2065, Australia, Tel +61 29463 2934, Fax +61 2 9463 2099, Email Aim: Recent data have identified specific symptom and polysomnographic profiles associated with cardiovascular disease (CVD) in patients with obstructive sleep apnoea (OSA). Our aim was to determine whether these profiles were present at diagnosis of OSA in patients with established CVD and in those with high cardiovascular risk. Participants in the Sydney Sleep Biobank (SSB) database, aged 30– 74 years, self-reported presence of CVD (coronary artery disease, cerebrovascular disease, or heart failure). In those without established CVD, the Framingham Risk Score (FRS) estimated 10-year absolute CVD risk, categorised as "low" ( 20%). Groups were compared on symptom and polysomnographic variables. Results: 629 patients (68% male; mean age 54.3 years, SD 11.6; mean BMI 32.3 kg/m 2 , SD 8.2) were included. CVD was reported in 12.2%. A further 14.3% had a low risk FRS, 38.8% had an intermediate risk FRS, and 34.7% had a high risk FRS. Groups differed with respect to age, sex and BMI. OSA severity increased with established CVD and increasing FRS. The symptom of waking too early was more prevalent in the higher FRS groups (p=0.004). CVD and FRS groups differed on multiple polysomnographic variables; however, none of these differences remained significant after adjusting for age, sex, and BMI. Conclusion: Higher CVD risk was associated with waking too early in patients with OSA. Polysomnographic variations between groups were explained by demographic differences. Further work is required to explore the influence of OSA phenotypic characteristics on susceptibility to CVD. Keywords: obstructive sleep apnoea, cardiovascular disease Obstructive Sleep Apnoea (OSA) is a highly prevalent sleep disorder estimated to affect nearly one billion people globally. 1 Repetitive collapse of the pharyngeal airway promotes sympathetic activation, oxidative stress, inflammation, and mechanical strain on the heart, which mechanistically links OSA to the development of cardiovascular disease (CVD). 2 In recent years, there has been increasing recognition of OSA as a heterogenous disorder. 3,4 Specific phenotypes have been identified, 4–6 some of which have links to CVD. For example, an excessively sleepy symptom subtype has been linked to the development of CVD. 7 Similarly, polysomnographic variables such as hypoxia, 8,9 breathing disturbance during rapid eye movement (REM) sleep 10 and presence of periodic limb movements 8 may also predict cardiovascular outcomes over and above the apnoea hypopnoea index (AHI). It is unknown whether these same phenotypes are evident at diagnosis of OSA in both those with established CVD and in individuals without CVD but with elevated CVD risk, as assessed by Framingham Risk Score. 11 Our aims were firstly to characterise symptom and polysomnographic profiles that were associated with established CVD at diagnosis of OSA. Secondly, we aimed to see whether these same patterns were evident in those without CVD but with elevated CVD risk. We hypothesised that those with established CVD, and those with high CVD risk, would be more likely to be -Abstract Truncated-
neurosciences,clinical neurology